易普力(002096) - 2019 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2019 was ¥479,111,857.32, representing a 27.06% increase compared to ¥377,079,136.58 in the same period last year[9] - The net profit attributable to shareholders of the listed company was -¥25,447,656.02, a decrease of 15.26% from -¥22,079,436.53 in the previous year[9] - The basic earnings per share for the reporting period was -¥0.0685, a decline of 15.13% from -¥0.0595 in the same period last year[9] - The net loss for the current period was ¥26,148,304.95, compared to a net loss of ¥22,352,965.72 in the previous period, reflecting a deterioration in performance[64] - The operating profit for the current period was CNY -14,300,912.87, compared to CNY -3,108,538.68 in the previous period, indicating a significant decline[73] - The net profit for the current period was CNY -14,300,912.87, worsening from CNY -2,930,153.04 in the previous period[73] Cash Flow - The net cash flow from operating activities improved by 28.18%, amounting to -¥117,219,237.96 compared to -¥163,203,517.90 in the same period last year[9] - Cash flow from operating activities was CNY -117,219,237.96, an improvement from CNY -163,203,517.90 in the previous period[79] - Cash received from operating activities totaled CNY 495,708,065.63, up from CNY 479,530,542.05 in the previous period[79] - Cash paid for operating activities was CNY 612,927,303.59, a decrease from CNY 642,734,059.95 in the previous period[79] - The net cash flow from investing activities was -469,540.05, compared to -3,392,033.79 in the previous period, showing a significant reduction in losses[86] - Cash inflow from financing activities was 440,000,000.00, up from 380,000,000.00 in the previous period[90] - The net cash flow from financing activities was 48,776,299.08, down from 148,598,883.31 in the previous period[90] Assets and Liabilities - The total assets at the end of the reporting period were ¥3,776,519,668.68, reflecting a 1.39% increase from ¥3,724,664,009.11 at the end of the previous year[9] - The total liabilities of the company were CNY 1,758,762,199.98, up from CNY 1,692,819,297.86, representing an increase of about 3.9%[48] - The company's equity attributable to shareholders decreased to CNY 1,977,849,759.68 from CNY 1,990,922,753.30, a decline of approximately 0.7%[51] - Total liabilities reached ¥1,692,819,297.86, with current liabilities at ¥1,522,529,552.58 and non-current liabilities at ¥170,289,745.28[94] - The company's total current assets reached CNY 1,920,307,247.58, compared to CNY 1,877,053,704.08 at the end of 2018, reflecting a growth of approximately 2.3%[45] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 16,394, with the top ten shareholders holding a significant portion of the shares[13] - The company did not engage in any repurchase transactions among the top ten ordinary shareholders during the reporting period[19] Operational Changes and Commitments - The company is currently planning a strategic restructuring with Hunan Weapon Industry Group, which is progressing without any transactions related to the company[25] - The company has committed to not engaging in any direct or indirect competition with its related enterprises in the explosive materials sector[26] - The company has committed to minimizing related party transactions and ensuring they are conducted at fair market prices[32] - The company guarantees that its subsidiaries will maintain complete operational independence, including assets, personnel, and market capabilities[32] Investment and Financial Management - The company reported a total investment cost of ¥65,000,000 for stocks, with a cumulative fair value change of ¥22,500,000, resulting in a year-end amount of ¥95,000,000[33] - The total investment in financial assets amounts to ¥84,792,700, with a cumulative investment income of ¥7,100,000[33] - The company has ongoing construction projects valued at ¥132,409,905.11, indicating potential future asset growth[94] Other Financial Metrics - The company received government subsidies amounting to ¥1,218,092.05 during the reporting period[9] - Other comprehensive income surged by 200.68% to 21,599,992.25 from 7,183,811.40, driven by increased fair value of investments[22] - Research and development expenses for the current period were ¥9,083,776.57, down from ¥10,700,414.69 in the previous period, suggesting a reduction in investment in innovation[62] - The company has not reported any delays in fulfilling its commitments, indicating effective management and adherence to its operational strategies[32]